Cassie Shipherd Group Candidate, Maria Sainz Elected to Orthofix International Board of Directors.
Orthofix International N.V. announced that Maria Sainz has been elected to the company's Board of Directors.
The Cassie Shipherd Group places Jerry Belle on PDI Board of Directors.
PDI, a provider of commercialization services to the biopharmaceutical industry, announced the appointment of Gerald P. Belle to the Company's Board of Directors. Mr. Belle's appointment expands the number of Board members to 10.
Antares Pharma Hires Cassie-Shipherd Group Candidate.
We have successfully completed the Search for Vice President, Clinical and Regulatory Affairs for Antares Pharma with the appointment of Kaushik J. Dave, Ph.D., R.PH., MBA.
The Cassie Shipherd Group has successfully completed the Search for Chairman of the Board for Celator Pharmaceuticals with appointment of Joseph A. Mollica, Ph.D.
PRINCETON, NJ, - Celator Pharmaceuticals, a biotechnology company working to develop improved combination chemotherapy, announced today that Joseph A. Mollica, Ph.D., chairman of Pharmacopeia Drug Discovery Inc., has been named chairman of the Celator board of directors.
We have successfully completed the Search for the SRI Surgical Chief Executive Officer and Director with the placement of GERALD WOODARD.
TAMPA, Fla., -- SRI/Surgical Express, Inc. (SRI), a leading provider of reusable surgical device reprocessing services supporting the healthcare industry, announces the appointment of Gerald Woodard as its Chief Executive Officer. Mr. Woodard starts with SRI as its CEO on January 31, 2008. He will also serve as a member of SRI's Board of Directors. SRI is a public company traded on the NASDAQ (STRC).
The Cassie Shipherd Group has successfully completed the Search for Vice President of Research and Development for Eleme Medical Inc., (formerly SmoothShapes) with the appointment of William H. McGrail.
Bill joins Eleme Medical after 20 years in ever increasing positions of responsibility at Candela Corporation.
The Cassie Shipherd Group is pleased to announce the placement of Tedd R. Gosian as Director of Clinical Operations for Histogenics.
Tedd joins Histogenics from Thoratec Corporation where he was the Clinical Research Manager.
Cassie-Shipherd places Thomas W. Barrett as Senior Vice President, Manufacturing at Keystone Dental, Inc.
Tom was most recently the Senior Vice President of Operations for the Orthopedic and Endoscopy Divisions of Accellent Corporation. Prior to his position at Accellent he spent 13 years at Stryker Corporation in ever increasing positions of responsibility.
"Jim Frontero appointed as CEO and President of Straumann USA"
(The Cassie Shipherd Group initially placed Jim at Straumann in 2005 as Senior Vice President of Sales)
Straumann, a global leader in implant dentistry and oral tissue regeneration, has appointed Jim Frontero as CEO and President of Straumann USA, LLC. Mr Frontero is a highly experienced manager with an impressive track record. His career includes 19 years in Sales and Marketing in the Medical Device industry, giving him a thorough understanding of customer requirements and service. These qualities make him ideally suited to lead Straumann's rapidly growing US business into the next stage of its development.
"Histogenics hires Cassie Shipherd Group candidate."
The Cassie Shipherd Group is pleased to announce the successful completion of the Search for the Vice President of Regulatory/Clinical Affairs for Histogenics Corporation with the appointment of Theresa G. Wingrove, Ph.D. Histogenics, soon to be located in their new facility in Waltham, MA., is a leader in the research and development of cartilage regeneration technologies. They are entering Phase II clinical trials, and Theresa will be leading that effort.
"Robert Churinetz, Cassie Shipherd candidate joins SBi as Vice President, Worldwide Manufacturing & Operations"
Robert Churinetz joins SBi as Vice President, Worldwide Manufacturing & Operations, and is responsible for all manufacturing and operational activities at SBi's Morrisville, PA and Bourg-en-Bresse, France facilities, as well as its contract manufacturing partners.
"Cassie-Shipherd Group candidate, Thomas B. Loring, joins SBi as Vice President, Worldwide Product Development"
Thomas B. Loring joins SBi as Vice President, Worldwide Product Development, and is responsible for SBi's global product development efforts in the US, France, as well as SBI's outside co-development partners. He comes to SBi from Osteotech, Inc. where he was Senior Director of Product Development and Orthobiologics. In this role, Mr. Loring led all research and development efforts on bone/polymer composite biomaterials.
"The Cassie Shipherd Group makes placement at PDI, INC."
Toms River, NJ - TCSG is pleased to announce that PDI, Inc. a diversified sales and marketing services company, has selected Kevin Connolly as Executive Vice President and General Manager, Medical Education and Communication. In this role, Mr. Connolly will lead PDI's Pharmakon and Edcomm business units.
